Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

This biopharma firm develops therapies for B-cell malignancies and autoimmune diseases, with a focus on oncology and ...

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of ...

Monoclonal antibodies are among the most widely used biologic medicines, with applications ranging from cancer treatment to ...

When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...

TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...

A two-drug combination frequently used in anti-aging research causes brain damage in mice, report University of Connecticut researchers in the Proceedings of the National Academy of Sciences. The ...